Mengxia Zhang

Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up

Mengxia Zhang, Jing Li, Guo‐Ping Shen et al. · European Journal of Cancer · 2015 · 321 citations

Medicine, Oncology, Radiation Oncology +9

Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma

Rui You, You‐Ping Liu, Pei‐Yu Huang et al. · JAMA Oncology · 2020 · 248 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis

Kun Zhang, Zhemin Shi, Mengxia Zhang et al. · Cell Death and Disease · 2020 · 108 citations · Full text

Life Sciences, Immunology, Pathology +17

Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma

Rui You, Rui Sun, Yi‐Jun Hua et al. · International Journal of Cancer · 2017 · 49 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial

Yi‐Jun Hua, Rui You, Zhiqiang Wang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 40 citations · Full text

Medicine, Oncology, Radiation Oncology +14